Ozempic Maker Novo Nordisk, After Trial Disappointment, Expands AI Deal in Potential $4.6 Billion Pact

Ozempic制造商诺和诺德，在试验失望后，扩大人工智能合作，潜在达46亿美元的协议

MarketWatch · 01/08 07:08

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登录免费看全文

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Ozempic Maker Novo Nordisk, After Trial Disappointment, Expands AI Deal in Potential $4.6 Billion Pact

Ozempic Maker Novo Nordisk, After Trial Disappointment, Expands AI Deal in Potential $4.6 Billion Pact

风险及免责提示

声明